John P. Saharek serves as the Chief Commercial Officer, as well as the Chief Executive Officer and President of ImprimisRx at HARROW INC. With a wealth of experience in the pharmaceutical industry, Saharek has been instrumental in driving the growth and success of HARROW INC. His leadership and strategic vision have been key factors in the company's ability to develop and deliver innovative pharmaceutical solutions to its customers. Prior to joining HARROW INC., Saharek held various senior leadership positions in the pharmaceutical sector. His extensive background includes expertise in sales, marketing, and business development, which he has leveraged to build strong relationships with key stakeholders and drive revenue growth. Saharek's ability to identify and capitalize on market opportunities has been a significant asset to HARROW INC., as the company continues to expand its product offerings and reach new markets. As the Chief Commercial Officer, Saharek is responsible for overseeing the company's commercial operations, including sales, marketing, and customer service. In his role as CEO and President of ImprimisRx, he leads the strategic direction of the division, focusing on the development and commercialization of compounded pharmaceuticals. Under Saharek's leadership, ImprimisRx has become a trusted provider of high-quality, customized medications, helping to improve patient outcomes and enhance the overall healthcare experience.